Provenance du réseau au premier degré de Ramanath Bhandari
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
Revopsis Therapeutics, Inc.
 Revopsis Therapeutics, Inc. BiotechnologyHealth Technology Revopsis Therapeutics, Inc. is a company based in Dover, DE. Ramanath Bhandari has been the CEOs since incorporation. Revopsis Therapeutics, Inc. was founded by Ram Palanki, Ramanath Bhandari, Jeff Olson.
2
| Holding Company | Biotechnology | 2 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Ramanath Bhandari via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| Albany College of Pharmacy & Health Sciences | College/University | Doctorate Degree | |
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Rutgers State University of New Jersey | College/University | Corporate Officer/Principal | |
| OXURION NV | Pharmaceuticals: Major | Sales & Marketing | |
| REGENXBIO INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Santen, Inc.
 Santen, Inc. Medical SpecialtiesHealth Technology Part of Santen Pharmaceutical Co., Ltd., Santen, Inc. is a company that develops ophthalmic products. The company is based in Emeryville, CA. The company was founded in 1993 by Adrienne L. Graves. Tatsuya Kaihara has been the CEO of the company since 2017. | Medical Specialties | Corporate Officer/Principal | |
Thrombogenics, Inc.
 Thrombogenics, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Oxurion NV, Thrombogenics, Inc. operates as a biotechnology company that delivers innovative treatments for diseases of the back of the eye, with a focus on diabetic eye disease. The company is based in New York, NY. | Miscellaneous Commercial Services | Sales & Marketing | |
AAVantgarde Bio Srl
 AAVantgarde Bio Srl Miscellaneous Commercial ServicesCommercial Services AAVantgarde Bio Srl is an Italian company that provides scientific research and development services. The company is based in Milan, Italy. The company was founded by Alberto Auricchio. Natalia Misciattelli has been the CEO of the company since 2022. | Miscellaneous Commercial Services | Chairman | |
| EYENOVIA, INC. | Pharmaceuticals: Major | Director/Board Member |
Statistiques
Internationale
| Etats-Unis | 8 |
| France | 2 |
| Belgique | 2 |
| Italie | 2 |
Sectorielle
| Health Technology | 7 |
| Consumer Services | 3 |
| Commercial Services | 3 |
Opérationnelle
| Corporate Officer/Principal | 4 |
| Sales & Marketing | 3 |
| Director/Board Member | 3 |
| Founder | 2 |
| Doctorate Degree | 1 |
Relations les plus connectées
| Insiders | |
|---|---|
| Ram Palanki | 11 |
| Jeff Olson | 1 |
- Bourse
- Insiders
- Ramanath Bhandari
- Connexions Sociétés
